Occudo Quantitative Strategies’s LeMaitre Vascular LMAT Stock Holding History

Occudo Quantitative Strategies’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	11,345 +6,716	+145%	+$689K	0.06%	367
2026 Q1	$508K	Buy	+4,629	New	+$441K	0.03%	493
2025 Q1	–	Sell	-3,413	Closed	-$314K	–	800
2024 Q4	$314K	Buy	3,413 +569	+20%	+$54.7K	0.06%	438
2024 Q3	$264K	Sell	2,844 -2,916	-51%	-$253K	0.05%	501
2024 Q2	$474K	Buy	5,760 +14	+0.2%	+$1.03K	0.08%	309
2024 Q1	$381K	Sell	5,746 -5,356	-48%	-$331K	0.07%	395
2023 Q4	$630K	Buy	+11,102	New	+$582K	0.09%	319

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Occudo Quantitative Strategies's LMAT Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its LeMaitre Vascular (LMAT) stake by 145% in Q2 2026, buying an estimated $689K and bringing the position to 11,345 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #367.

Occudo Quantitative Strategies first reported a position in LMAT in Q4 2023 and has held it in 7 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Occudo Quantitative Strategies held 11,345 shares of LeMaitre Vascular worth $1.09M as of Q2 2026.
Occudo Quantitative Strategies bought 6,716 LeMaitre Vascular shares in Q2 2026, an estimated $689K.
LeMaitre Vascular made up 0.06% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #367 holding.
Occudo Quantitative Strategies first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 7 quarters since.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.